A Sustainable Chromatographic Method for Simultaneous Analysis of Fluoxetine and Olanzapine Antidepressants: Assessment of Greenness with Green Metric Tools .

Abstract

The combination of Fluoxetine HCL and Olanzapine treats depression in bipolar disorder and patients unresponsive to other antidepressants. The research aims to optimize a sensitive, simple, rapid, reliable, eco-friendly liquid chromatographic method by minimizing feedstock’s, reagents, energy, and waste to protect the environment and conserve resources, additionally assessed the environmental impact of a method using various green metric tools, and applied the method to pharmaceuticals. The separation was conducted using isocratic RP-HPLC with a DAD at 227nm. The mobile phase used was a 40:40:20 (v/v/v) ratios of buffer, acetonitrile, and ethanol. An L1 column (150 x 4.6mm, 5µm) was utilized with a flow rate of 1.5mL/min and injection volume of 5µL. The column oven and auto-sampler were both maintained at 45°C and 25°C respectively. The optimized method was validated as per ICH guidelines and found to be specific, precise, and robust to slight changes in mobile phase flow, column temperature, and buffer pH. Linearity was demonstrated from 0.1-150µg/mL for olanzapine and 0.4-610µg/mL for fluoxetine HCL. The accuracy was tested with recovery ranges of 0.1–157 µg/mL for olanzapine and 0.4–606 µg/mL for fluoxetine HCl in tablet placebo, and 0.1–150 µg/mL for olanzapine and 0.4–605 µg/mL for fluoxetine HCl in capsule placebo, indicating that the method is suitable for both tablet and capsule dosage forms. The method’s greenness was evaluated using AES, NEMI, GAPI, and AGREE tools. The optimized method was successfully applied to pharmaceutical analysis. The newly optimized method found simple, sensitive, rapid, eco-friendly, incorporating green analytical concepts, has been successfully achieved for the identification and quantification of Fluoxetine HCL and Olanzapine present in pharmaceuticals.